ABT reports Thursday, Jan 28, 2027, before the open. After the last 4 reports the stock moved −1.9%, +10.7%, −6.0%, −10.0% the next day.
ABT is expected to report on Thursday, Jan 28, 2027, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Oct 21, 2026 | 1.42 | 1.42 | −1.9% | +0.6% |
| Jul 16, 2026 | 1.28 | 1.31 | +10.7% | +12.7% |
| Apr 16, 2026 | 1.15 | 1.15 | −6.0% | −9.7% |
| Jan 22, 2026 | 1.49 | 1.50 | −10.0% | −12.2% |
| Oct 15, 2025 | 1.30 | 1.30 | −2.9% | −4.3% |
| Jul 17, 2025 | 1.26 | 1.26 | −8.5% | −4.5% |
| Apr 16, 2025 | 1.07 | 1.09 | +2.8% | +2.9% |
| Jan 22, 2025 | 1.34 | 1.34 | +0.8% | +9.1% |
Average move the next trading day over the last 8 reports: ±5.5% (3 of 8 up).
ABT is in an uptrend, momentum firm. $110.61 is the level overhead; $104.55 the first support below.
ABT at $109.40. Nearest resistance $110.61 (+1.1%). Nearest support $104.55 (−4.4%).
ABT chart, levels and analysis · Latest analysis: Abbott Laboratories (ABT) stock analysis, November 3, 2026: Uptrend intact, stock presses just under $110.61 resistance · Earnings this week
ABT is expected to report on Thursday, Jan 28, 2027, before the open.
ABT reports before the open, US Eastern time.
After its report on Oct 21, 2026, ABT moved −1.9% the next trading day.
Over the last 8 reports, ABT moved 5.5% on average the next trading day, up 3 times out of 8.